MEMSCAP® has been chosen by American implantable devices specialist, CardioMEMS, for its FDA cleared EndoSure Wireless AAA Pressure Sensor. MEMSCAP® manufacturing technology is a key element of this revolutionary tool used in the endovascular repair of abdominal aortic aneurysms.

It is the first wireless, un-powered, permanently implantable pressure sensor for human use to be commercially available in the United States. The hermetically sealed circuit is inserted during the same procedure as the stent graft. Once in place, an antenna held over patient’s abdomen uses RF energy to measure pressure inside the aneurysm sac. The process of measuring the pressure causes no discomfort whatsoever to the patient. A real-time pressure measurement can be obtained as frequently as desired subsequent to its implantation.

David Stern, President and CEO of CardioMEMS, explains:
"We chose MEMSCAP as the key supplier for our EndoSure Sensor because we needed a partner with proven expertise in medical applications. CardioMEMS is engaged in providing its customers with breakthrough solutions, and MEMSCAP’s certified manufacturing and track-record for medical solutions in severe environments brought us the accuracy and reliability we were looking for". "This first product is part of a global roadmap between MEMSCAP and CardioMEMS".

"The CARMAT patented artificial heart prototype respects the iocompatibility criteria enabling its implantation in the human body. Its features are similar to a biological heart, both on the physiological and the anatomy levels. The system, composed from an implantable part, a portable part as well as external devices supplying power and assuring its control and monitoring, integrates MEMSCAP sensors to automatically regulate cardiac output and frequency in function of the patient physiological needs, such as physical effort.

Marc Grimmé, Technical Director of CARMAT, explains:
“MEMSCAP has been selected as we needed a partner having a strong experience in Microsystems capable of supplying us high quality products with extreme precision and very low time drift, showing strong robustness for many years”.

Already available in some European countries, the new PillCam™ COLON is expected to be launched globally as regulatory approvals are granted. It is the newest addition to Given Imaging’s product line including its PillCam capsule endoscopes for the small bowel and the esophagus, the Agile Patency capsule, the RAPID Workstation and Given’s proprietary data recorders. The PillCam COLON visualizes the colon to help physicians diagnose diseases of the colon. MEMSCAP MEMS-based magnetic switch activates the pill when presented to the patient.

“We chose MEMSCAP for our PillCam COLON because of their state-of-the art technology, the reliability of their products and the future benefits that they may bring to our products”, explains Kevin Rubey, Chief Operating Officer at Given Imaging.

The combined experience and technologies of MEMSCAP and OrthoMEMS enables the development and commercialization of the OrthoChip, a miniature, battery-less, wireless pressure sensor that will provide an objective measurement of spinal disc pressures. The OrthoChip is designed to detect clear-cut pressure differences between normal and mechanically unstable spinal segments and to communicate the results telemetrically to a read-out unit. This new capability is expected to significantly alter indications for surgery and non-surgical treatments. No other technology, existing or emerging, provides this advantage.
“MEMSCAP has a clear track record of success in developing and manufacturing high value added MEMS sensors for medical use. This strategic partnership adds real value across our full product cycle – from the design-in phase to the market launch of our ground-breaking product that changes the way clinicians interact with the human body,” said Douglas Lee, Chairman and CEO of OrthoMEMS.

Back to Success Stories

Office to Contact

North America:
Phone : +1 (919) 248-4102
Contact Us

Latest News


Completion of the FABLITE Program Read more


Read more

All news items